Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04549246 · ClinicalTrials.gov registry record

Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities.

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
83
Enrollment target

NCT04549246: Completed study, sponsored by Mayo Clinic.

NCT04549246 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04549246 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
83 participants
Enrollment target

Study Summary

This study is an observational registry study evaluating the clinical outcomes of grid therapy. Subjects will be screened at outpatient clinic visit appointments and interested qualified subjects will be consented and offered participation in this study. Once consent has been obtained, baseline adverse event and QOL data will be collected and subjects will undergo grid therapy and follow-up at 2-4 weeks (for toxicity), and 3-6 months (for toxicities and radiographic control) then per clinical discretion up to 1 year. Patients will be evaluated according to the physician's standard practice and discretion. Patient data will be drawn from the patients' medical records and reported by means of a web-based electronic data collection (EDC) system. Patients will be considered "on study" until 60 months of observation has occurred, withdrawal of consent, lost to follow-up, or study closure. See below for the clinical visit flowchart for data collected at baseline and standard clinic visits.

Interventions

  • RADIATION Spatially Fractionated Radiation (GRID) Therapy

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2020-06-18
Est. Completion 2024-06-01

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04549246

The ClinicalTrials.gov registry entry for NCT04549246 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Spatially Fractionated Radiation (GRID) Therapy is the first listed.

NCT04549246 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04549246 about?

NCT04549246 is a clinical study titled "Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities.". This study is an observational registry study evaluating the clinical outcomes of grid therapy. Subjects will be screened at outpatient clinic visit appointments and interested qualified subjects will be consented and offered participation in this study. Once consent has been obtained, baseline adve...

What is the current status of trial NCT04549246?

This trial is currently completed. The enrollment target is 83 participants. The study started on 2020-06-18. Estimated completion is 2024-06-01.

What interventions are being tested in trial NCT04549246?

The interventions under investigation include: Spatially Fractionated Radiation (GRID) Therapy (RADIATION).

Who is sponsoring clinical trial NCT04549246?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.